Global Cancer Pain Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 145905
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 133
  • list Pharmaceuticals and Healthcare

Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response.

Scope of the Report:

This report focuses on the Cancer Pain Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Factors such as the unmet medical needs of patients drive the market growth during the forecast period. Currently, the drugs that are available for reducing pains associated with cancer have a prolonged duration of action and are characterized by undesirable effects like sedation and respiratory depression. Consequently, this presents an opportunity for the vendors to bring in therapies with fewer side effects and a better efficacy parameter.

The worldwide market for Cancer Pain Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

BioDelivery Science

ProStrakan Group

Teva pharmaceuticals

Eli-Lilly

Grunenthal Group

GW Pharmaceuticals

Johnson＆Johnson

Meda Pharmaceuticals

Orexo

Sanofi

WEX Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Opioids

Non-Steroidal Anti-Inflammatory Drugs

Others

Market Segment by Applications, can be divided into

Paracetamol Treatment-Related Immunotherapy

Radiotherapy

Chemotherapy

Hormone Therapy

There are 15 Chapters to deeply display the global Cancer Pain Therapeutics market.

Chapter 1, to describe Cancer Pain Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Pain Therapeutics, with sales, revenue, and price of Cancer Pain Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Pain Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Pain Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Pain Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Cancer Pain Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Opioids

1.2.2 Non-Steroidal Anti-Inflammatory Drugs

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Paracetamol Treatment-Related Immunotherapy

1.3.2 Radiotherapy

1.3.3 Chemotherapy

1.3.4 Hormone Therapy

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 BioDelivery Science

2.1.1 Business Overview

2.1.2 Cancer Pain Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 BioDelivery Science Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 ProStrakan Group

2.2.1 Business Overview

2.2.2 Cancer Pain Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 ProStrakan Group Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Teva pharmaceuticals

2.3.1 Business Overview

2.3.2 Cancer Pain Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Teva pharmaceuticals Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli-Lilly

2.4.1 Business Overview

2.4.2 Cancer Pain Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli-Lilly Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Grunenthal Group

2.5.1 Business Overview

2.5.2 Cancer Pain Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Grunenthal Group Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GW Pharmaceuticals

2.6.1 Business Overview

2.6.2 Cancer Pain Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GW Pharmaceuticals Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Johnson＆Johnson

2.7.1 Business Overview

2.7.2 Cancer Pain Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Johnson＆Johnson Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Meda Pharmaceuticals

2.8.1 Business Overview

2.8.2 Cancer Pain Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Meda Pharmaceuticals Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Orexo

2.9.1 Business Overview

2.9.2 Cancer Pain Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Orexo Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Sanofi

2.10.1 Business Overview

2.10.2 Cancer Pain Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Sanofi Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 WEX Pharmaceuticals

2.11.1 Business Overview

2.11.2 Cancer Pain Therapeutics Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 WEX Pharmaceuticals Cancer Pain Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Pain Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Pain Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Pain Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Pain Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Pain Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Pain Therapeutics Market Analysis by Regions

4.1 Global Cancer Pain Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Pain Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Pain Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

5 North America Cancer Pain Therapeutics by Countries

5.1 North America Cancer Pain Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Pain Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Pain Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

6 Europe Cancer Pain Therapeutics by Countries

6.1 Europe Cancer Pain Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Pain Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Pain Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

6.4 France Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Pain Therapeutics by Countries

7.1 Asia-Pacific Cancer Pain Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Pain Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Pain Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

7.5 India Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

8 South America Cancer Pain Therapeutics by Countries

8.1 South America Cancer Pain Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Pain Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Pain Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Pain Therapeutics by Countries

9.1 Middle East and Africa Cancer Pain Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Pain Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Pain Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Pain Therapeutics Sales and Growth Rate (2013-2018)

10 Global Cancer Pain Therapeutics Market Segment by Type

10.1 Global Cancer Pain Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Pain Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Pain Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Opioids Sales Growth and Price

10.2.1 Global Opioids Sales Growth (2013-2018)

10.2.2 Global Opioids Price (2013-2018)

10.3 Non-Steroidal Anti-Inflammatory Drugs Sales Growth and Price

10.3.1 Global Non-Steroidal Anti-Inflammatory Drugs Sales Growth (2013-2018)

10.3.2 Global Non-Steroidal Anti-Inflammatory Drugs Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Cancer Pain Therapeutics Market Segment by Application

11.1 Global Cancer Pain Therapeutics Sales Market Share by Application (2013-2018)

11.2 Paracetamol Treatment-Related Immunotherapy Sales Growth (2013-2018)

11.3 Radiotherapy Sales Growth (2013-2018)

11.4 Chemotherapy Sales Growth (2013-2018)

11.5 Hormone Therapy Sales Growth (2013-2018)

12 Cancer Pain Therapeutics Market Forecast (2018-2023)

12.1 Global Cancer Pain Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Pain Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Pain Therapeutics Market Forecast (2018-2023)

12.2.2 Europe Cancer Pain Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Pain Therapeutics Market Forecast (2018-2023)

12.2.4 South America Cancer Pain Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Pain Therapeutics Market Forecast (2018-2023)

12.3 Cancer Pain Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Pain Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Pain Therapeutics Market Share Forecast by Type (2018-2023)

12.4 Cancer Pain Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Pain Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Pain Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer Pain Therapeutics Picture

Table Product Specifications of Cancer Pain Therapeutics

Figure Global Sales Market Share of Cancer Pain Therapeutics by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery